NDC11 87682008001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 87682-0080-01 | 87682-0080 |
| 87682-0080-1 | 87682-0080 |
| 87682-080-01 | 87682-080 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Insulin Glargine-aldy | INSULIN GLARGINE-ALDY | Lanexa Biologics, LLC | 536a4b0a-4b7c-2d23-e063-6294a90a7b7c | 2026-07-20 | Warnings, Adverse reactions | 87682-080-01 87682-080 87682008001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.